박희호 (고려대학교)님 | 한빛사연구자 > 한빛사

고려대학교

CV File

최종업데이트 2025.07.10.

High-throughput multiplexed gene and cell doping analysis through CRISPR-Cas12a system integrated with blood direct PCR
- Sci. Adv., Jul 11 2025, 11 (28) | https://doi.org/10.1126/sciadv.adv7234
- 2025-07
- 바이오·의료융합
- 한빛사논문
Engineered Cell-Derived Nanovesicles with CAR and PH20 for Enhanced Targeted Photodynamic Cancer Therapy and Tumor Microenvironment Modulation
- Adv. Funct. Mater., Volume35, Issue25 June 19, 2025 2418138 | https://doi.org/10.1002/adfm.202418138
- 2025-06
- 바이오·의료융합
- 한빛사논문
The TOX-RAGE axis mediates inflammatory activation and lung injury in severe pulmonary infectious diseases
- Proc. Natl. Acad. Sci. USA, Jun 25 2024, 121 (26) | https://doi.org/10.1073/pnas.2319322121
- 2024-06
- 생명과학
- 한빛사논문
Improved Neural Inductivity of Size-Controlled 3D Human Embryonic Stem Cells Using Magnetic Nanoparticles
- Biomater. Res., 2024 Mar 15:28:0011 | https://doi.org/10.34133/bmr.0011
- 2024-03
- 바이오·의료융합
- 한빛사논문
Secured delivery of basic fibroblast growth factor using human serum albumin-based protein nanoparticles for enhanced wound healing and regeneration.
- J. Nanobiotechnol., Sep 02 2023, 21 (1) 310 | https://doi.org/10.1186/s12951-023-02053-4
- 2023-09
- 생명과학
- 한빛사논문
Free radical-scavenging composite gelatin methacryloyl hydrogels for cell encapsulation
- Acta Biomater., Volume 149, 1 September 2022, Pages 96-110 | https://doi.org/10.1016/j.actbio.2022.06.043
- 2022-09
- 생명과학
- 한빛사논문
Cleavage-Responsive Biofactory T Cells Suppress Infectious Diseases-Associated Hypercytokinemia
- Adv. Sci., First published: 25 June 2022 | https://doi.org/10.1002/advs.202201883
- 2022-06
- 바이오·의료융합
- 한빛사논문
Nanocomplex-mediated in vivo programming to chimeric antigen receptor-M1 macrophages for cancer therapy
- Adv. Mater., First published: 12 September 2021 | https://doi.org/10.1002/adma.202103258
- 2021-09
- 바이오·의료융합
- 한빛사논문
2D graphene oxide particles induce unwanted loss in pluripotency and trigger early differentiation in human pluripotent stem cells
- J. Hazard. Mater., Volume 414, 15 July 2021, 125472 | https://doi.org/10.1016/j.jhazmat.2021.125472
- 2021-07
- 바이오·의료융합
- 한빛사논문
Lung-selective 25-hydroxycholesterol nanotherapeutics as a suppressor of COVID-19-associated cytokine storm
- Nano Today, Available online 8 April 2021 | https://doi.org/10.1016/j.nantod.2021.101149
- 2021-04
- 바이오·의료융합
- 한빛사논문

연구자 ID

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기